Georgie Kovacs

Georgie Kovacs

Georgie Kovacs is a seasoned professional with over two decades of healthcare expertise, having made significant contributions at industry giants like Pfizer, Syneos Health, IQVIA, and Bristol-Myers Squibb. She has a background spanning healthcare strategy, entrepreneurship, and consulting. Georgie launched Fempower Health collaborating with top healthcare experts and femtech founders to redefine the narrative surrounding women's health.

NewsletterNewsletter
Why We Wait: A Question I’ve Been Thinking About

Why We Wait: A Question I’ve Been Thinking About

After a month of events, one pattern keeps coming up—and I want to hear your perspective.

Georgie Kovacs
Georgie Kovacs
Perimenopause & MenopausePerimenopause & Menopause
+3+3
FDA Reverses Course on Vaginal Estrogen, Dr. Sharon Malone Exposes the System, and Brain Health Takes Center Stage

FDA Reverses Course on Vaginal Estrogen, Dr. Sharon Malone Exposes the System, and Brain Health Takes Center Stage

From a long-overdue FDA update to the economics keeping women’s care undervalued, this week’s Fempower Health dives into how change finally happens — in policy, in practice, and in perception.

Georgie Kovacs
Georgie Kovacs
Midlife Midlife
+5+5
When the Brain Leads the Way in Women’s Health

When the Brain Leads the Way in Women’s Health

From hormones to healthcare systems, new research shows how understanding the brain could transform care for everyone.

Georgie Kovacs
Georgie Kovacs
Midlife Midlife
+2+2
When Hormones Confuse Healthcare: Progesterone vs. Progestin

When Hormones Confuse Healthcare: Progesterone vs. Progestin

The misunderstanding that still drives confusion in menopause care.

Georgie Kovacs
Georgie Kovacs
Midlife Midlife
+4+4
From ADHD to Action: Women’s Health Is Finally Getting Personal

From ADHD to Action: Women’s Health Is Finally Getting Personal

Policy. Advocacy. Mental health. From global change to daily realities, women’s health is evolving—and this week shows how.

Georgie Kovacs
Georgie Kovacs
Midlife Midlife
+6+6
When Science, Policy & Women’s Lives Collide

When Science, Policy & Women’s Lives Collide

From FDA hearings on menopause to breakthroughs reshaping women’s health, this week’s stories reveal how data, art, and advocacy are rewriting the narrative.

Georgie Kovacs
Georgie Kovacs
Reproductive YearsReproductive Years
+3+3
When Labels Lag: Depo-Provera Lawsuit, 2 Events + Roundup

When Labels Lag: Depo-Provera Lawsuit, 2 Events + Roundup

Post-market signals should move from studies → labels → EHRs → patient alerts. Inside: PMDD webinar, WH Horizons, FDA vaginal estrogen, IVF robotics.

Georgie Kovacs
Georgie Kovacs
Breaking TaboosBreaking Taboos
+1+1
👉 AI Won’t Fix Healthcare If It Ignores Women

👉 AI Won’t Fix Healthcare If It Ignores Women

Why women’s health data gaps put us at risk — and how AI could help if we get it right.

Georgie Kovacs
Georgie Kovacs
Midlife Midlife
+9+9
Pain, Policy & the Future of Women’s Health

Pain, Policy & the Future of Women’s Health

Chronic pain stories, FDA menopause deadline, this month’s top reads—and a sneak peek at AI in women’s health.

Georgie Kovacs
Georgie Kovacs
EndometriosisEndometriosis
+5+5
7 Powerful Conversations About Pain You Might Have Missed

7 Powerful Conversations About Pain You Might Have Missed

Conversations with leading experts on chronic pelvic pain, endometriosis, hypermobility, and more—so women don’t have to suffer in silence.

Georgie Kovacs
Georgie Kovacs